ExpreS2ion will participate in the 19th European Life Sciences Forum (ELSF), an international partnering and investor conference focused on biotechnology, pharmaceuticals, medtech, and digital health.

CFO Keith Alexander will present ExpreS2ion at 12:10 CET on Thursday, March 5th, providing an update on the Company’s proprietary ExpreS2 platform technology, the ES2B-C001 breast cancer vaccine program, and the broader pipeline. The presentation will outline recent progress, development strategy, and key upcoming milestones.

In addition to the presentation, ExpreS2ion will engage in one-on-one meetings with institutional investors, pharmaceutical companies, and potential strategic partners.

For more information about the event, please visit the official conference website:
https://www.sachsforum.com/19elsf-about.html